Eli Lilly's Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Eli Lilly announced on Monday that its obesity pill Foundayo significantly reduced the severity of obstructive sleep apnea in a late-stage trial. The drugmaker plans to submit the results to the U.S. FDA by the end of the year to seek approval for treating moderate-to-severe obstructive sleep apnea in adults with obesity or who are overweight.
Continue in the app — vote & join in ➔Source: CNBC Top News · via ahirlevel.hu